Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens

D. A. Goodwin, C. F. Meares, M. J. McCall, M. McTigue, W. Chaovapong

Research output: Contribution to journalArticle

194 Citations (Scopus)

Abstract

A method of tumor imaging utilizing the nonspecific accumulation of antibody through leaky capillaries is described, in which the antibody and the radiolabel are administered separately. Nonradioactive antibody is given first (pre-targeted), and allowed adequate time to reach maximum tumor concentration. Depending on the antibody, this may take several days. At the time of maximum tumor concentration of nonradioactive antibody, the blood is quickly cleared of excess circulating nonradioactive antibody using a special i.v. 'chase'. The radiolabel then is given and imaging done in 1 to 3 hr. The use of short lived tracers (hours) to image antibodies that localize slowly (days) in-vivo is made possible by this method.

Original languageEnglish (US)
Pages (from-to)226-234
Number of pages9
JournalJournal of Nuclear Medicine
Volume29
Issue number2
StatePublished - 1988
Externally publishedYes

Fingerprint

Indium
Haptens
Antibodies
Neoplasms

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Goodwin, D. A., Meares, C. F., McCall, M. J., McTigue, M., & Chaovapong, W. (1988). Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens. Journal of Nuclear Medicine, 29(2), 226-234.

Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens. / Goodwin, D. A.; Meares, C. F.; McCall, M. J.; McTigue, M.; Chaovapong, W.

In: Journal of Nuclear Medicine, Vol. 29, No. 2, 1988, p. 226-234.

Research output: Contribution to journalArticle

Goodwin, DA, Meares, CF, McCall, MJ, McTigue, M & Chaovapong, W 1988, 'Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens', Journal of Nuclear Medicine, vol. 29, no. 2, pp. 226-234.
Goodwin DA, Meares CF, McCall MJ, McTigue M, Chaovapong W. Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens. Journal of Nuclear Medicine. 1988;29(2):226-234.
Goodwin, D. A. ; Meares, C. F. ; McCall, M. J. ; McTigue, M. ; Chaovapong, W. / Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens. In: Journal of Nuclear Medicine. 1988 ; Vol. 29, No. 2. pp. 226-234.
@article{8e3873ba7eb44285b5843a05019308ff,
title = "Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens",
abstract = "A method of tumor imaging utilizing the nonspecific accumulation of antibody through leaky capillaries is described, in which the antibody and the radiolabel are administered separately. Nonradioactive antibody is given first (pre-targeted), and allowed adequate time to reach maximum tumor concentration. Depending on the antibody, this may take several days. At the time of maximum tumor concentration of nonradioactive antibody, the blood is quickly cleared of excess circulating nonradioactive antibody using a special i.v. 'chase'. The radiolabel then is given and imaging done in 1 to 3 hr. The use of short lived tracers (hours) to image antibodies that localize slowly (days) in-vivo is made possible by this method.",
author = "Goodwin, {D. A.} and Meares, {C. F.} and McCall, {M. J.} and M. McTigue and W. Chaovapong",
year = "1988",
language = "English (US)",
volume = "29",
pages = "226--234",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "2",

}

TY - JOUR

T1 - Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens

AU - Goodwin, D. A.

AU - Meares, C. F.

AU - McCall, M. J.

AU - McTigue, M.

AU - Chaovapong, W.

PY - 1988

Y1 - 1988

N2 - A method of tumor imaging utilizing the nonspecific accumulation of antibody through leaky capillaries is described, in which the antibody and the radiolabel are administered separately. Nonradioactive antibody is given first (pre-targeted), and allowed adequate time to reach maximum tumor concentration. Depending on the antibody, this may take several days. At the time of maximum tumor concentration of nonradioactive antibody, the blood is quickly cleared of excess circulating nonradioactive antibody using a special i.v. 'chase'. The radiolabel then is given and imaging done in 1 to 3 hr. The use of short lived tracers (hours) to image antibodies that localize slowly (days) in-vivo is made possible by this method.

AB - A method of tumor imaging utilizing the nonspecific accumulation of antibody through leaky capillaries is described, in which the antibody and the radiolabel are administered separately. Nonradioactive antibody is given first (pre-targeted), and allowed adequate time to reach maximum tumor concentration. Depending on the antibody, this may take several days. At the time of maximum tumor concentration of nonradioactive antibody, the blood is quickly cleared of excess circulating nonradioactive antibody using a special i.v. 'chase'. The radiolabel then is given and imaging done in 1 to 3 hr. The use of short lived tracers (hours) to image antibodies that localize slowly (days) in-vivo is made possible by this method.

UR - http://www.scopus.com/inward/record.url?scp=0023841413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023841413&partnerID=8YFLogxK

M3 - Article

C2 - 3346734

AN - SCOPUS:0023841413

VL - 29

SP - 226

EP - 234

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 2

ER -